Resumen: We evaluated coenzyme Q10 (CoQ) levels in patients studied under suspicion of mitochondrial DNA depletion syndromes (MDS) (n = 39). CoQ levels were quantified by HPLC, and the percentage of mtDNA depletion by quantitative real-time PCR. A high percentage of MDS patients presented with CoQ deficiency as compared to other mitochondrial patients (Mann–Whitney-U test: p = 0.001). Our findings suggest that MDS are frequently associated with CoQ deficiency, as a possible secondary consequence of disease pathophysiology. Assessment of muscle CoQ status seems advisable in MDS patients since the possibility of CoQ supplementation may then be considered as a candidate therapy. Idioma: Inglés DOI: 10.1016/j.mito.2013.04.001 Año: 2013 Publicado en: MITOCHONDRION 13, 4 (2013), 337-341 ISSN: 1567-7249 Factor impacto JCR: 3.524 (2013) Categ. JCR: GENETICS & HEREDITY rank: 52 / 164 = 0.317 (2013) - Q2 - T1 Categ. JCR: CELL BIOLOGY rank: 85 / 184 = 0.462 (2013) - Q2 - T2 Tipo y forma: Artículo (Versión definitiva) Área (Departamento): Área Bioquímica y Biolog.Mole. (Dpto. Bioq.Biolog.Mol. Celular)